FDA approves use for Lymphoseek to help doctors determine extent of neck and cancer

[News]

The U.S. Food and Drug Administration today approved a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent used to help doctors determine the extent a type of cancer called squamous cell carcinoma has spread in the body's head and neck region.

More... (http://www.news-medical.net/news/20140616/FDA-approves-use-for-Lymphoseek-to-help-doctors-determine-extent-of-neck-and-cancer.aspx)